Skip to search formSkip to main contentSkip to account menu

NovoLog Mix 70/30

Known as: NovoLog Mix 70:30, NovoMix 30 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

insulin aspart, insulin aspart protamine drug combination 30:70

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Application of Premixed Insulin NovoMix®30 and NovoRapid® as Multiple Daily Injections or as Basal Bolus Format in Selected Diabetic Patients: Practical Evidence from Prospective Case Series
Managing type-1 or type-2 diabetes by insulin is one of the best techniques, especially for type-2 diabetics after oral… 
2016
2016
IDENTIFIKASI PENGGUNAAN OBAT PADA PASIEN DIABETES MELLITUS TIPE II USIA LANJUT DENGAN BEER’S CRITERIA DI INSTALASI RAWAT INAP RUMAH SAKIT IBNU SINA MAKASSAR PERIODE TAHUN 2012
U sing identif ication in the use medicine  with Beer 's C riteria to the advanced age patients in Inpatient installation in Ibnu… 
2013
2013
W1428/13 Angående utsänd påstått bedräglig information kring prissänkning av insulinerna NovoRapid FlexPen, NovoMix FlexPen, Insulatard FlexPen, Levemir FlexPen
2013
2013
Evaluasi Cara Penggunaan Insulin Injeksi Pada Pasien Diabetes Mellitus Di RSUD Dr. Moewardi Surakarta
Diabetes mellitus adalah kondisi kronis yang pengobatannya menggunakan obat hipoglikemik oral dan bila tidak tercapai target… 
2009
2009
Novomix® 30 hat bei dreimal täglicher Gabe ein vergleichbares Wirkprofil wie eine Basis-Bolus-Therapie mit den Analog-Insulinen Glargin und Glulisine
Review
2009
Review
2009
A PROSPECTIVE, OPEN-LABELLED, NON-CONTROLLED OBSERVATIONAL STUDY TO ASSESS DOCTOR PREFERENCE ON FLEXPEN™ FOR TREATMENT OF DIABETES MELLITUS
Background: The accuracy and convenience of pen devices for insulin injection have improved quality of life for patients with… 
2009
2009
Significant Improvements in Glycaemic Control with BIAsp 30 in Clinical Reality: Experience from Clinical Practice in Macedonia
This was a prospective, multicenter, 24-week observational study of the effectiveness and safety of biphasic insulin aspart 30… 
2009
2009
Biphasisches Insulinaspart 70 (BIAsp 70, NovoMix(R) 70) in der intensivierten konventionellen Insulintherapie bei Typ-2-Diabetes: Eine österreichische Anwendungsbeobachtung
Biphasic Insulin Aspart 70 (BIAsp 70, NovoMix® 70) in Intensified Conventional Therapy in Patients with Type-2-Diabetes: an… 
2008
2008
L'insuline novomix® 50: Quid novi?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)